Physician profile
Shandy Whitaker
NPI 1275266843
$439.72
in general payments reported to CMS, 2019-2025
13 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $18.18 · 2024: $167 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $439.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $145.36 | 2025 | Zurzuvae |
| Astellas Pharma US INC | $48.32 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $42.91 | 2025 | Aptima, Fluent Fluid Management System |
| Mayne Pharma Commercial LLC | $32.62 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.47 | 2024 | |
| Array Biopharma INC | $23.44 | 2024 | Mektovi, Braftovi, Lorbrena |
| Sumitomo Pharma America, INC. | $20.19 | 2024 | Myfembree |
| Organon LLC | $18.18 | 2023 | Nexplanon |
| Abbvie INC. | $18.13 | 2025 | |
| Millicent US INC | $16.98 | 2024 | Intrarosa |
| Coopersurgical, INC. | $16.76 | 2024 | Paragard T 380a |
| Ethicon US, LLC | $16.16 | 2025 | Vistaseal, Dermabond Prineo |
| Heron Therapeutics, INC. | $15.20 | 2025 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shandy Whitaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.